Antithyroid drug treatment for Graves' disease: baseline predictive models of relapse after treatment for a patient-tailored management.
Masiello E, Veronesi G, Gallo D, Premoli P, Bianconi E, Rosetti S, Cusini C, Sabatino J, Ippolito S, Piantanida E, Tanda ML, Chiovato L, Wiersinga WM, Bartalena L.
Masiello E, et al. Among authors: tanda ml.
J Endocrinol Invest. 2018 Dec;41(12):1425-1432. doi: 10.1007/s40618-018-0918-9. Epub 2018 Jun 26.
J Endocrinol Invest. 2018.
PMID: 29946800